Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

FBP Appreciation & Income Opportunities Fund (FBPBX)

17.77
Net Asset Value
-0.17%
1 Day
-6.18%
Year-to-Date
Overall Morningstar Rating
Aggressive allocation
Style or Category
No Load
Sales Expenses
1.05%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks long term capital appreciation and current income, assuming a moderate level of investment risk. The fund seeks to achieve its objectives by investing in a portfolio of both equity and fixed income securities. It will invest primarily in companies with market capitalizations of $1 billion or more. Fixed income securities include corporate debt obligations, U.S. government obligations and shares of ETFs that invest primarily in corporate debt obligations and U.S. government obligations.

Performance

1 month-1.17% 3 years+11.50%
3 months-3.13% 5 years+8.37%
1 year-1.65% Since inception+7.48%
Data through --

Peer Comparisonvs. Aggressive allocation

 FBPBXCategory
Performance 5-yr return+8.37%+11.75%
Expense ratio1.05%1.37%
Risk 5 year sharpe ratio0.901.06
Net assets$38.0M$1.0B
Average market cap$54.5B$32.9B
Average P/E15.618.6
Portfolio turnover12%12%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyFlippin, Bruce & Porter Funds
Fund manager & tenureJohn Bruce / 26 Years
Minimal initial investment$5,000.00
Minimum IRA investment$1,000.00

Holdings

U.S. stock67.77%
Cash23.12%
International stock5.22%
Fixed income3.90%
Other0.00%
Top 5 Sectors
Portfolio weighting
Financial service 19.53%
Consumer service 12.02%
Consumer goods 11.45%
Industrial materials 10.96%
Energy 10.53%
Top 10 Holdings
Portfolio weighting
JPM JPMorgan Chase3.16%
CSCO Cisco2.83%
BAC Bank of America2.73%
AAPL Apple2.68%
MET Metlife2.59%
LNC Lincoln National Corp2.58%
JNJ Johnson & Johnson2.58%
PFE Pfizer2.50%
MRK Merck2.07%
COP ConocoPhillips2.00%